Sales and Marketing

Showing 15 posts of 11526 posts found.

Opdivo

BMS’ Opdivo improves lung cancer survival

May 29, 2015 Research and Development, Sales and Marketing ASCO, BMS, Bristol-Myers Squibb, NSCLC, lung cancer, nivolumab, non-small cell lung cancer, opdivo

A Phase III trial of Bristol-Myers Squibb’s immunotherapy Opdivo has found it increases overall survival in people with a common …
novartis_window

NICE green-light for Novartis skin drug

May 29, 2015 Sales and Marketing Cosentyx, IL-17, NICE, Novartis, Secukinumab

NICE has released positive draft guidance for three treatments, including the first in a new generation of psoriasis drugs. Novartis’ …
Pfizer image

Pfizer gets first approval for rare lung disease

May 29, 2015 Sales and Marketing FDA, Pfizer, Rapamune, lung disease

Pfizer’s Rapamune will become the first drug available to treat the very rare lung disease lymphangioleiomyomatosis (LAM) after receiving approval …

Teva settles generic ‘pay-to-delay’ case for $1.2 billion

May 29, 2015 Sales and Marketing Cephalon, FTC, Teva, modafinil, provigil

Teva Pharmaceuticals has agreed to a $1.2 billion settlement for paying generic drug makers to delay challenging the patent for …
Merkel image

Sanofi plays host to German chancellor Angela Merkel

May 29, 2015 Manufacturing and Production, Medical Communications, Sales and Marketing France, Germany, Sanofi, angela, brett wells, merkel

German Chancellor Dr Angela Merkel met with Sanofi bosses in Frankfurt to discuss antibiotics and open a new manufacturing facility. …
screen_shot_2015-05-29_at_07

Huntingdon and Harlan names corporate marketing VP

May 29, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Huntingdon and Harlan, joseph bedford

UK’s Huntingdon Life Sciences and Harlan Laboratories has appointed Dr Joseph Bedford to serve as corporate vice president of global …
lilly

Two new diabetes drugs approved

May 28, 2015 Sales and Marketing Japan, Takeda, diabetes in China, lilly

Two new diabetes offerings from Lilly and Takeda are now available for patients in the US and Japan after they …
Eisai image

Eisai seeks new ALS drug approval

May 28, 2015 Sales and Marketing Eisai, Japan, als, mecobalamin

Eisai is hoping that existing neurology drug mecobalamin can be a new option for the difficult-to-treat condition amyotrophic lateral sclerosis …
valeant_pharma

Actavis and Valeant see FDA approval for IBS drugs

May 28, 2015 Sales and Marketing Actavis, FDA, IBS, Valeant, brett wells

Both Actavis and Valeant have been shown the green light for their respective irritable bowel syndrome (IBS) treatments from the …
NICE image

NICE sets out office for market access plans

May 28, 2015 Sales and Marketing ABPI, EMA, NHS, NICE, eams, market access

The UK healthcare watchdog NICE is to set up a new office for market access to advise pharma companies on …
patrizia_paterlini-brechot

Kayentis names four committee members

May 28, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Patrizia Paterlini-Brechot, Pierre-Olivier Goineau, Ronan Roussel, Stephen Senn, kayentis

French software solutions provider for clinical trials Kayentis has formed a strategic committee comprising four industry veterans.  Accepting director Guillaume …

Another Chinese health official arrested for corruption

May 27, 2015 Medical Communications, Sales and Marketing China, GSK, bribery, huang fenping, wang yu

A Chinese health official has been arrested on accusations of bribery as the country continues to crack down on corruption …
Novartis image

Novartis reveals ASCO plans

May 27, 2015 Sales and Marketing ASCO, GSK, Novartis

Novartis’ first ASCO conference since buying GlaxoSmithKline’s oncology business will be showcasing drugs from the acquisition. The two firms swapped …
amgen

Amgen cold sore virus drug shows ‘significant’ cancer benefit

May 27, 2015 Research and Development, Sales and Marketing Amgen, Cancer, cold sore, t-vec

Amgen is pinning its hopes on investigational viral treatment T-VEC following promising results from a ‘landmark’ skin cancer study. People …
fycompa

Eisai epilepsy drug sees EMA nod

May 27, 2015 Research and Development, Sales and Marketing Eisai, Fycompa, ema. epilepsy

Eisai’s UK subsidiary has received a positive opinion from the European Medicines Agency for using Fycompa for the adjunctive treatment …
The Gateway to Local Adoption Series

Latest content